Pierina Danos

Ms. Pierina Danos

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2020 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
ESErica V. Stelmaszewski
Erica V. Stelmaszewski
DPDaniella B. Parente
Daniella B. Parente
AFAlberto Farina
Alberto Farina
ASAnna Stein
Anna Stein
AMAnthony Gutiérrez Martínez
Anthony Gutiérrez Martínez
KLKarla L. Loss
Karla L. Loss
Introduction: Tuberous sclerosis complex is a rare genetic disorder leading to the growth of hamartomas in multiple organs, including cardiac rhabdomyomas. Children with symptomatic cardiac rhabdomyoma require frequent admissions to intensive care units, have major complications, namely, arrhythmias, cardiac outflow tract obstruction and heart failure, affecting the quality of life and taking on high healthcare cost. Currently, there is no standard pharmacological treatment for this condition, and the management includes a conservative approach and supportive care. Everolimus has shown positive effects on subependymal giant cell astrocytomas, renal angiomyolipoma and refractory seizures associated with tuberous sclerosis complex. However, evidence supporting efficacy in symptomatic cardiac rhabdomyoma is limited to case reports. The ORACLE trial is the first randomised clinical trial assessing the efficacy of everolimus as a specific therapy for symptomatic cardiac rhabdomyoma.Methods: ORACLE is a phase II, prospective, randomised, placebo-controlled, double-blind, multicentre protocol trial. A total of 40 children with symptomatic cardiac rhabdomyoma secondary to tuberous sclerosis complex will be randomised to receive oral everolimus or placebo for 3 months. The primary outcome is 50% or more reduction in the tumour size related to baseline. As secondary outcomes we include the presence of arrhythmias, pericardial effusion, intracardiac obstruction, adverse events, progression of tumour reduction and effect on heart failure.Conclusions: ORACLE protocol addresses a relevant unmet need in children with tuberous sclerosis complex and cardiac rhabdomyoma. The results of the trial will potentially support the first evidence-based therapy for this condition.

28 June 2017 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
JBJosé Luis Buleje
José Luis Buleje
MGMaría L. Guevara-Fujita
María L. Guevara-Fujita
OAOscar Acosta
Oscar Acosta
FHFrancia D. P. Huaman
Francia D. P. Huaman
PDPierina Danos
Pierina Danos
RFRicardo FUJITA
Ricardo FUJITA
Background Breast cancer is one of the most prevalent malignancies in the world. In Peru, breast cancer is the second cause of death among women. Five to ten percent of patients present a high genetic predisposition due to BRCA1 and BRCA2 germline mutations. Methods We performed a comprehensive analysis of BRCA1 and BRCA2 genes by Sanger sequencing and multiplex ligation‐dependent probe amplification (MLPA) to detect large rearrangements in patients from 18 families, which met the criteria for hereditary breast cancer. Results In this series, we found four pathogenic mutations, three previously reported (BRCA1: c.302‐1G>C and c.815_824dup10; BRCA2: c.5946delT) and a duplication of adenines in exon 15 in BRCA1 gene (c.4647_4648dupAA, ClinVar SCV000256598.1). We also found two exonic and four intronic variants of unknown significance and 28 polymorphic variants. Conclusion This is the first report to determine the spectrum of mutations in the BRCA1/BRCA2 genes in Peruvian families selected by clinical and genetic criteria. The alteration rate in BRCA1/BRCA2 with proven pathogenic mutation was 22.2% (4 out 18) and this finding could be influenced by the reduced sample size or clinical criteria. In addition, we found three known BRCA1/BRCA2 mutations and a BRCA1 c.4647_4648dupAA as a novel pathogenic mutation.

3 March 2018 in Molecular Genetics and Genomics
Verified
Journal Article
Open access
PDF file
Jose Raul Sandoval SandovalJose Raul Sandoval Sandoval
Jose Raul Sandoval Sandoval
DLDaniela R. Lacerda
Daniela R. Lacerda
MJMarilza S. Jota
Marilza S. Jota
RERonald Elward
Ronald Elward
OAOscar Acosta
Oscar Acosta
RFRicardo FUJITA
Ricardo FUJITA
This study focuses on the descendants of the royal Inka family. The Inkas ruled Tawantinsuyu, the largest pre-Columbian empire in South America, which extended from southern Colombia to central Chile. The origin of the royal Inkas is currently unknown. While the mummies of the Inka rulers could have been informative, most were destroyed by Spaniards and the few remaining disappeared without a trace. Moreover, no genetic studies have been conducted on present-day descendants of the Inka rulers. In the present study, we analysed uniparental DNA markers in 18 individuals predominantly from the districts of San Sebastian and San Jerónimo in Cusco (Peru), who belong to 12 families of putative patrilineal descent of Inka rulers, according to documented registries. We used single-nucleotide polymorphisms and short tandem repeat (STR) markers of the Y chromosome (Y-STRs), as well as mitochondrial DNA D-loop sequences, to investigate the paternal and maternal descent of the 18 alleged Inka descendants. Two Q-M3* Y-STR clusters descending from different male founders were identified. The first cluster, named AWKI-1, was associated with five families (eight individuals). By contrast, the second cluster, named AWKI-2, was represented by a single individual; AWKI-2 was part of the Q-Z19483 sub-lineage that was likely associated with a recent male expansion in the Andes, which probably occurred during the Late Intermediate Period (1000–1450 AD), overlapping the Inka period. Concerning the maternal descent, different mtDNA lineages associated with each family were identified, suggesting a high maternal gene flow among Andean populations, probably due to changes in the last 1000 years.

10 September 2020 in BMC Genomics
Verified
Journal Article
Open access
PDF file
Jose Raul Sandoval SandovalJose Raul Sandoval Sandoval
Jose Raul Sandoval Sandoval
DLDaniela R. Lacerda
Daniela R. Lacerda
MJMarilza M. S. Jota
Marilza M. S. Jota
PRPaulo Robles-Ruiz
Paulo Robles-Ruiz
PDPierina Danos
Pierina Danos
RFRicardo FUJITA
Ricardo FUJITA
Background: According to history, in the pre-Hispanic period, during the conquest and Inka expansion in Ecuador, many Andean families of the Cañar region would have been displaced to several places ofTawantinsuyu, including Kañaris, a Quechua-speaking community located at the highlands of the Province of Ferreñafe, Lambayeque (Peru). Other families were probably taken from the Central Andes to a place close to Kañaris, named Inkawasi. Evidence of this migration comes from the presence near the Kañaris–Inkawasi communities of a village, a former Inka camp, which persists until the present day. This scenario could explain these toponyms, but it is still controversial. To clarify this historical question, the study presented here focused on the inference of the genetic relationship between ‘Cañaris’ populations, particularly of Cañar and Ferreñafe, compared to other highland populations. We analysed native patrilineal Y chromosome haplotypes composed of 15 short tandem repeats, a set of SNPs, and maternal mitochondrial DNA haplotypes of control region sequences.Results: After the genetic comparisons of local populations—three from Ecuador and seven from Peru—, Y chromosome analyses (n = 376) indicated that individuals from the Cañar region do not share Y haplotypes with the Kañaris, or even with those of the Inkawasi. However, some Y haplotypes of Ecuadorian ‘Cañaris’ were associated with haplotypes of the Peruvian populations of Cajamarca, Chivay (Arequipa), Cusco and Lake Titicaca, an observation that is congruent with colonial records. Within the Kañaris and Inkawasi communities there are at least five clans in which several individuals share haplotypes, indicating that they have recent common ancestors. Despite their relative isolation, most individuals of both communities are related to those of the Cajamarca and Chachapoyas in Peru, consistent with the spoken Quechua and their geographic proximity. With respect to mitochondrial DNA haplotypes (n = 379), with the exception of a shared haplotype of the D1 lineage between the Cañar and Kañaris, there are no genetic affinities.Conclusion: Although there is no close genetic relationship between the Peruvian Kañaris (including Inkawasi) and Ecuadorian Cañar populations, our results showed some congruence with historical records.

1 July 2026 in eLife
Verified
Journal Article
Open access
PGPriyanka Gajwani
Priyanka Gajwani
LWLi Wang
Li Wang
KDKoushik Debnath
Koushik Debnath
PDPierina Danos
Pierina Danos
YKYoung-Mee Kim
Young-Mee Kim
JRJalees Rehman
Jalees Rehman
Eukaryotic mitochondria are characterized by several features that represent vestiges of their prokaryotic ancestry. One such feature is the N-terminal formylation of proteins encoded by mitochondrial DNA that undergo translation by mitochondrial ribosomes. N-formylated proteins are also released by bacteria and trigger activation of immune cells such as neutrophils. Growing evidence indicates that circulating levels of mitochondrial formyl proteins are elevated in the serum of patients with excessive inflammatory responses. However, the mechanisms by which they are released into circulation are not known. In this study, we have identified vascular endothelial cells as a source of Pink1-dependent release of mitochondrial formyl proteins in response to inflammatory mediators. Mechanistically, the mitophagy mediator Pink1 is stabilized by inflammatory activation of endothelial cells, promoting mitophagy and mitochondrial formyl peptide release both in mice and primary human endothelial cells. Using nanoparticle delivery of Pink1 -targeting sgRNA in mice expressing endothelial-specific Cas9, we developed a mouse model in which Pink1 is specifically depleted in the endothelium. Deletion of endothelial Pink1 decreased circulating formyl peptide levels, lowered lung neutrophil infiltration and reduced mortality in mice. We thus propose that endothelial cells upregulate pro-inflammatory mitophagy in response to inflammation, leading to the release of mitochondrial formyl peptides and detrimental neutrophil recruitment into the lung.

19 December 2024 in Revista Argentina de Antropología Biológica
Verified
Journal Article
Open access
PDF file
Jose Raul Sandoval SandovalJose Raul Sandoval Sandoval
Jose Raul Sandoval Sandoval
PDPierina Danos
Pierina Danos
Fabrício R. SantosFabrício R. Santos
Fabrício R. Santos
RFRicardo FUJITA
Ricardo FUJITA
Es conocido que las actuales poblaciones peruanas son el resultado de la contribución de los bagajes genéticos, fundamentalmente de América, Eurasia y África. Asimismo, que el mestizaje inicialmente se dio generalmente entre el varón europeo y la mujer autóctona peruana. Sin embargo, hay pocos estudios relacionados al estudio genético de los haplogrupos alóctonos. Así, usando la combinación de SNPs y STRs del cromosoma Y (herencia patrilineal), el presente estudio traza la inmigración masculina alóctona del periodo poscolombino, y desvela que ese componente constituye cerca del 23% de la población peruana. De esta proporción, se observa que la mayor contribución realizada es por parte del haplogrupo R1b (frecuente en la península ibérica y a lo largo de Europa occidental), seguida de E1b1b (frecuente en norte de África y el Mediterráneo). Igualmente, hay una contribución de otros haplogrupos, aunque en pequeñas proporciones. Nuestros resultados corroboran que la contribución paterna alóctona en el acervo genético peruano es principalmente de las poblaciones europeas y africanas. Por su parte, a través de la secuenciación de la región control del ADN mitocondrial, los datos muestran que en las poblaciones peruanas hay una baja frecuencia de distintos haplogrupos maternos alóctonos (~ 3%) en comparación a la mayor parte del legado prehispánico.